
Specializes in gene therapy, offering process development, viral vector production, and integrated solutions for clinical applications in the biopharmaceutical industry.
Baltimore
Baltimore City
Maryland
Workers Affected
32
Notice Date
August 20, 2025
October 18, 2025
Unavailable
Unavailable
Unavailable
Unavailable
Unavailable
31 Manufacturing
Unavailable
Unavailable
Unavailable
More WARN Notices from